Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5801)
All Articles published online
|
Publishing Process of This Article
|
Mar 26, 2021 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiao H, Ma K, Huang D, Liu XG, Liu TH, Liu Q, Liu GZ, Song T, Tao W, Wu DS, Wang YX, Yang XQ, Zhang XM, Liu H, Liu YQ. Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain. World J Clin Cases 2021; 9(9): 2100-2109 [PMID: 33850929 DOI: 10.12998/wjcc.v9.i9.2100] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i9/2100.htm |
| Number | Citing Articles |
| 1 |
Xiaocui Li, Xiaowen Ou, Jiadong Ni, Yihong Xu, Huilin Zuo, Yu Fu, Caihua Yang, Zhongxiang Zhao, Na Li, Hua Zhou, Rong Zhang, Zhongqiu Liu, Ling Fu, Lijun Zhu. Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions. Toxicology and Applied Pharmacology 2022; 445: 116024 doi: 10.1016/j.taap.2022.116024
|
| 2 |
Ke Ma, Zhixiang Cheng, Hao Jiang, Zhangya Lin, Chuansheng Liu, Xianguo Liu, Lijuan Lu, Yan Lu, Wei Tao, Suoliang Wang, Xiaoqiu Yang, Qishan Yi, Xiaomei Zhang, Ying Zhang, Yanqing Liu. Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China. Journal of Pain Research 2024; : 953 doi: 10.2147/JPR.S445171
|
| 3 |
Yi Li, Kaoru Toyama, Takafumi Nakatsu, Hitoshi Ishizuka, Hailan Wu, Guoying Cao, Jicheng Yu, Yu Wang, Xiaofen Liu, Beining Guo, Jufang Wu, Peimin Yu, Zhen Hong, Jing Zhang, Xiaojie Wu. Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study. Advances in Therapy 2023; 40(4): 1628 doi: 10.1007/s12325-022-02424-7
|
| 4 |
Morgan R. Price, Kaelyn E. Mead, Diana M. Cowell, Alyssa M. Troutner, Tyler E. Barton, Sheryl A. Walters, Clinton J. Daniels. Medication recommendations for treatment of lumbosacral radiculopathy: A systematic review of clinical practice guidelines. PM&R 2024; 16(10): 1128 doi: 10.1002/pmrj.13142
|
| 5 |
Yi Shi, Yanbin Wu, Liangzhe Wang, Bingke Bai, Xuhui He, Hongrui Wang, Chengzhong Zhang, Jinzhong Wu, Dan Jia, Yuanjie Zhu, Chengjian Zheng. Gooderoside A from Anoectochilus elatus attenuates acute and chronic pains by inhibiting NO/cGMP and IRAK4/IRAK1/TAK1 signaling pathways. Journal of Ethnopharmacology 2024; 324: 117767 doi: 10.1016/j.jep.2024.117767
|
| 6 |
Xin-Yi Xiao, Yan-Ming Chen, Jin Zhu, Ming-Yue Yin, Chao-Nan Huang, Hui-Min Qin, Shu-Xian Liu, Yang Xiao, Heng-Wei Fang, Tao Zhuang, Yin Chen. The synergistic anti-nociceptive effects of nefopam and gabapentinoids in inflammatory, osteoarthritis, and neuropathic pain mouse models. European Journal of Pharmacology 2024; 977: 176738 doi: 10.1016/j.ejphar.2024.176738
|
| 7 |
Dan-dan Zhang, Qiao-qiao Chen, Li Yao. Geniposide Alleviates Neuropathic Pain in CCI Rats by Inhibiting the EGFR/PI3K/AKT Pathway And Ca2+ Channels. Neurotoxicity Research 2022; 40(4): 1057 doi: 10.1007/s12640-022-00531-5
|
| 8 |
O. I. Butranova, S. K. Zyryanov. Use of gabapentin for neuropathic pain therapy: A view from perspective of evidence-based medicine. Pharmacy & Pharmacology 2024; 12(1): 74 doi: 10.19163/2307-9266-2024-12-1-74-88
|